Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Battle of GLP-1 delivery technologies
HTML
PDF
Details
Locations
Year:
2018
Type:
review
Source:
Advanced Drug Delivery Reviews
DOI:
10.1016/j.addr.2018.07.009
Authors:
Minzhi Yu,
Mason M. Benjamin,
Santhanakrishnan Srinivasan,
Emily E. Morin,
Ekaterina I. Shishatskaya,
Steven P. Schwendeman,
Anna Schwendeman
show all 7
Institutions:
University of Michigan,
Institute of Biophysics,
Siberian Federal University
Language:
English
Topic:
Diabetes Treatment and Management
Subfield:
Endocrinology, Diabetes and Metabolism
Field:
Medicine
Domain:
Health Sciences
Keywords:
GLP-1 receptor agonists,
drug delivery technology,
half-life extension,
type 2 diabetes,
PEGylation,
fatty acid conjugation,
Fc fusion,
sustained drug release,
pharmacokinetics,
pharmacodynamics,
peptide therapeutics,
commercial success
show all 12
SDG:
Good health and well-being
Open Access status:
bronze
Funders:
Amneal Pharmaceuticals,
National Institutes of Health,
National Heart, Lung, and Blood Institute,
National Institute of General Medical Sciences
Awards:
KLF14 and Cardiovascular Disease,
Training Program in Translational Cardiovascular Research and Entrepreneurship,
Cellular Biotechnology Training Program (CBTP),
G7005273825,
Cellular Biotechnology Training Program (CBTP) - Years 31-35
OpenAlex ID:
W2883953772
FWCI:
1.896
Cites:
175
Cited by:
195
Related to:
10